Literature DB >> 20041353

Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention.

Horacio Gómez-Acevedo1, Michael Y Li, Steven Jacobson.   

Abstract

Human T-cell leukaemia/lymphoma virus type I (HTLV-I) is a retrovirus that has been identified as the causative agent of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and other illnesses. HTLV-I infects primarily CD4(+) T cells and the transmission occurs through direct cell-to-cell contact. HAM/TSP patients harbor higher proviral loads in peripheral blood lymphocytes than asymptomatic carriers. Also, HAM/TSP patients exhibit a remarkably high number of circulating HTLV-I-specific CD8(+) cytotoxic T lymphocytes (CTLs) in the peripheral blood. While CTLs have a protective role by killing the infected cells and lowering the proviral load, a high level of CTLs and their cytotoxicity are believed to be a main cause of the development of HAM/TSP. A mathematical model for HTLV-I infection of CD4(+) T cells that incorporates the CD8(+) cytotoxic T-cell (CTL) response is investigated. Our mathematical analysis reveals that the system can stabilize at a carrier steady-state with persistent viral infection but no CTL response, or at a HAM/TSP steady-state at which both the viral infection and CTL response are persistent. We also establish two threshold parameters R(0) and R(1), the basic reproduction numbers for viral persistence and for CTL response, respectively. We show that the parameter R(1) can be used to distinguish asymptomatic carriers from HAM/TSP patients, and as an important control parameter for preventing the development of HAM/TSP.

Entities:  

Mesh:

Year:  2009        PMID: 20041353      PMCID: PMC4758685          DOI: 10.1007/s11538-009-9465-z

Source DB:  PubMed          Journal:  Bull Math Biol        ISSN: 0092-8240            Impact factor:   1.758


  28 in total

Review 1.  The dynamics of HTLV-I and the CTL response.

Authors:  D Wodarz; M A Nowak; C R Bangham
Journal:  Immunol Today       Date:  1999-05

2.  Population dynamics of immune responses to persistent viruses.

Authors:  M A Nowak; C R Bangham
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

3.  The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.

Authors:  J E Kaplan; M Osame; H Kubota; A Igata; H Nishitani; Y Maeda; R F Khabbaz; R S Janssen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

4.  Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus).

Authors:  F Mortreux; M Kazanji; A S Gabet; B de Thoisy; E Wattel
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro.

Authors:  B Macchi; I Faraoni; J Zhang; S Grelli; C Favalli; A Mastino; E Bonmassar
Journal:  J Gen Virol       Date:  1997-05       Impact factor: 3.891

6.  Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton.

Authors:  Tadahiko Igakura; Jane C Stinchcombe; Peter K C Goon; Graham P Taylor; Jonathan N Weber; Gillian M Griffiths; Yuetsu Tanaka; Mitsuhiro Osame; Charles R M Bangham
Journal:  Science       Date:  2003-02-13       Impact factor: 47.728

7.  In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy.

Authors:  L M Mansky
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease.

Authors:  S Koenig; R M Woods; Y A Brewah; A J Newell; G M Jones; E Boone; J W Adelsberger; M W Baseler; S M Robinson; S Jacobson
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

9.  Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients.

Authors:  A Manns; E L Murphy; R Wilks; G Haynes; J P Figueroa; B Hanchard; M Barnett; J Drummond; D Waters; M Cerney
Journal:  Blood       Date:  1991-02-15       Impact factor: 22.113

Review 10.  The immune control of HTLV-1 infection: selection forces and dynamics.

Authors:  Charles R M Bangham; Kiran Meekings; Frederic Toulza; Mohamed Nejmeddine; Endre Majorovits; Becca Asquith; Graham P Taylor
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  6 in total

1.  Stable and transient periodic oscillations in a mathematical model for CTL response to HTLV-I infection.

Authors:  John Lang; Michael Y Li
Journal:  J Math Biol       Date:  2011-07-27       Impact factor: 2.259

2.  Modeling brain lentiviral infections during antiretroviral therapy in AIDS.

Authors:  Weston C Roda; Michael Y Li; Michael S Akinwumi; Eugene L Asahchop; Benjamin B Gelman; Kenneth W Witwer; Christopher Power
Journal:  J Neurovirol       Date:  2017-05-16       Impact factor: 2.643

3.  Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1.

Authors:  Lies Boelen; Bisrat Debebe; Marcos Silveira; Arafa Salam; Julia Makinde; Chrissy H Roberts; Eddie C Y Wang; John Frater; Jill Gilmour; Katie Twigger; Kristin Ladell; Kelly L Miners; Jyothi Jayaraman; James A Traherne; David A Price; Ying Qi; Maureen P Martin; Derek C Macallan; Chloe L Thio; Jacquie Astemborski; Gregory Kirk; Sharyne M Donfield; Susan Buchbinder; Salim I Khakoo; James J Goedert; John Trowsdale; Mary Carrington; Simon Kollnberger; Becca Asquith
Journal:  Sci Immunol       Date:  2018-11-09

4.  Modeling and analysis of a within-host HIV/HTLV-I co-infection.

Authors:  A M Elaiw; N H AlShamrani
Journal:  Bol Soc Mat Mex       Date:  2021-03-29

5.  Stability of an HTLV-HIV coinfection model with multiple delays and CTL-mediated immunity.

Authors:  N H AlShamrani
Journal:  Adv Differ Equ       Date:  2021-05-25

6.  Dynamics of HIV-1/HTLV-I Co-Infection Model with Humoral Immunity and Cellular Infection.

Authors:  Noura H AlShamrani; Matuka A Alshaikh; Ahmed M Elaiw; Khalid Hattaf
Journal:  Viruses       Date:  2022-08-04       Impact factor: 5.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.